Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nobody on this board knows any more than you do. Every thing here is speculation. GLTU
UUGH!!!!
We need movement
That's quite a post
MERRY CHRISTMAS
MERRY CHRISTMAS
NotifiMED from fusz might be a perfect fit for Healthlynked
FUSZ has so much uncertainty for SP to go up. Like how many reverse splits will be needed? Will they authorize more shares?
News out
NAPLES, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced that the Company will be attending the HIMSS Global Conference & Exhibition (Healthcare Information and Management Systems Society) taking place on February 11-15, 2019 in Orlando, Florida. The HIMSS Global Conference & Exhibition is the leading health information and technology conference, bringing together 45,000+ professionals from 90+ countries for the education, innovation and collaboration they need to transform healthcare through information and technology.
Physicians attending the HIMSS conference are encouraged to stop by our booth #6793 to activate their HealthLynked account and learn more about the benefits of being a HealthLynked provider. HealthLynked offers physicians a wide range of tools that optimize medical practices, save time, and increase patient engagement. HealthLynked has rapidly been expanding its innovative platform technologies that connect doctors, patients and their data to improve healthcare.
“I look forward to attending the upcoming HIMSS conference in Orlando, Florida next February. Our participation at the FMA conference in August this year was a huge success and Physicians are extremely receptive to becoming a part of the HealthLynked network, recognizing the value we bring to the Doctor-Patient relationship and how we improve healthcare,” said Michael Dent, M.D., Chairman and Chief Executive Officer of HealthLynked. “Attending events like the HIMSS conference helps us reach physicians and rapidly grow our network of Providers. We are also excited to meet with companies that share our vision to improve healthcare through innovative technologies and Artificial Intelligence “AI” as we continue to develop powerful strategic relationships.”
HIMSS is a non-profit global caused-based organization, whose goals are to promote the best use of information technology and management systems in the healthcare industry. HIMSS is the leader to optimize health engagements and care outcomes by using information technology. The conference will feature exceptional world class speakers, new cutting-edge products and powerful networking opportunities that are the foundation of this leading industry conference.
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge.
Participating healthcare providers can connect with their current and future patients through the system. Other benefits to providers include the ability to utilize the HealthLynked marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancelations using our “real time appointment scheduling” all within our mobile application. Healthcare providers pay a monthly fee to access these HealthLynked services.
For additional information about HealthLynked Corp. visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.
Forward Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q and in other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov.
Continue reading
Start the conversation
Sign in to post a message.
HealthLynked Reports Third Quarter 2018 Financial Results
GlobeNewswire•November 15, 2018
HealthLynked Revenue Increased 19% Year-to-Date Compared to the Same Period in 2017
NAPLES, Fla., Nov. 15, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK), a provider of healthcare-related technology which connects doctors, patients and medical data, reported financial results for the three months ended September 30, 2018.
Year-to-Date & Third Quarter 2018 Compared to Year-to-Date & Third Quarter 2017 Highlights:
19% increase in revenue YTD’18 compared to YTD’17
12% increase in revenue in Q3’18 compared to Q3’17
$71,599 improvement in operating income in our health services division in Q3’18 compared to Q3’17
$4,889 health services division operating income YTD’18 compared to ($187,664) YTD’17, a $192,553 improvement
Patient appointments increased 18% from 3,300 in Q3’17 to 3,909 in Q3’18
Time of Service collections increased 21% from $94,759 in Q3’17 to $114,194 in Q3’18
Third Quarter 2018 Compared to Second Quarter 2018 Highlights:
5% decrease in revenue to $539,625 in Q3’18 compared to $566,320 in Q2’18
Patient appointments decreased 3% from 4,010 in Q2’18 to 3,909 in Q3’18
Time of Service collections decreased 25% from $152,174 in Q2’18 to $114,194 in Q3’18
Year-to-date revenues of 2018 were $1,751,584, an increase of 19% over the same period in 2017. Revenues for the third quarter of 2018 were $539,625, an increase of 12% over the same period in 2017, mainly caused by an increase in patient appointments of 18%, along with an increase in time of service collections of 21%. Year-to-date average revenue per patient decreased by 2% compared to the same period last year.
The Company’s health services division realized operating income of $4,889 YTD’18, compared to an operating loss of ($187,664) YTD’17, an improvement of $192,553.
Third quarter 2018 revenue was $539,625, a decrease of 5% over second quarter 2018 revenue of $566,320. Revenue per physician increased 27% in Q3’18 to approximately $180,000 per quarter, compared to approximately $142,000 per quarter in Q2’18, with one less physician in Q3’18, who was replaced in October 2018.
Patient appointments in Q3’18 decreased 3% compared to Q2’18 and time of service collections decreased 25%. Average revenue per patient increased by 5% compared to Q2’18. There was a 9% increase in deliveries in Q3’18 compared to Q2’18.
Dr. Michael Dent, Chairman and CEO of HealthLynked, stated, "We are pleased with the results of our health services division, with revenue having a 19% growth reported year-to-date based upon a 15% increase in patient appointments during 2018 compared to the same period last year, and improvement in time of service collections of 46% during 2018 compared to during the same period last year. We believe these two metric improvements are a direct result of the implementation of the HealthLynked network into our health services division."
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge.
Participating healthcare providers can connect with their current and future patients through the system. Other benefits to providers include the ability to utilize the HealthLynked marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancelations using our “real time appointment scheduling” all within our mobile application. Healthcare providers pay a monthly fee to access these HealthLynked services.
For additional information about HealthLynked Corp. visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.
Forward Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q and in other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov.
Company Contact:
George O’Leary
Chief Financial Officer
goleary@healthlynked.com
Investor Relations contact:
Jim Hock
Hanover International Inc.
Investor Relations
jh@hanoverintlinc.com
Contact:
Start the conversation
Sign in to post a message.
HealthLynked Corp. Announces the Addition of Dr. Maher Albitar to its Scientific Advisory Board
GlobeNewswire•November 6, 2018
NAPLES, Fla., Nov. 06, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced that Maher Albitar M.D. will be joining the company’s Scientific Advisory Board (SAB).
HealthLynked is an innovative digital healthcare company connecting doctors, patients, and their data. The company has developed a number of software applications that allow patients to connect with the healthcare providers they choose, share medical information and provide personal healthcare recommendations to its members.
The advisory position will assist in expanding the company’s current business objectives, aid in technology advances, navigating the changing healthcare landscape and developing strategic relationships.
Maher Albitar, M.D.
Dr. Maher Albitar is the founder and CEO of Genomic Testing Cooperative, LCA. Dr. Albitar has extensive experience in Anatomic/Clinical Pathology, Hematopathology and Molecular Pathology. He also has extensive business and administrative experience as an executive leader of large laboratories, board member, and director of large scientific and genomic diagnostic studies. Dr. Albitar was the Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics.
He is credited with transforming NeoGenomics Laboratories from a FISH testing company to a company offering the most sophisticated molecular testing.
Prior to NeoGenomics, Dr. Albitar served as the Medical Director for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics, and Chief R&D for Hematopathology and Oncology for Quest Diagnostics from 2003 to 2010.
From 1991 to 2003, Dr. Albitar held various faculty positions at the University of Texas MD Anderson Cancer Center, including Section Chief of Leukemia Section in Laboratory Medicine and Pathology Department, Director of the Molecular Laboratory and Director of the Hematopathology Fellowship Program. Dr. Albitar was a tenured full professor in Pathology and Leukemia at the time of leaving MD Anderson Cancer Center. Dr. Albitar is certified AP/CP Pathologist with fellowship training in Hematopathology and Molecular Pathology. After his training in Hematopathology, Dr. Albitar spent 4 years in Physician/Scientist training program at the University of Pennsylvania/Howard Hughes Medical Institute and the Department of Genetics.
Dr. Albitar has published more than 300 peer-reviewed papers, book chapters, and review articles. He is the lead inventor on more than 50 different patents and patent applications.
Dr. Michael Dent, CEO stated, “The vision for the HealthLynked SAB is to create a diverse group of healthcare experts that will provide direction in creating the healthcare of the future. I have worked with Dr. Maher during his time at NeoGenomics and his creativity and drive to innovate is amazing. He is a true leader in cutting edge molecular and genetic diagnostics. I am honored to have him on the SAB of HealthLynked.”
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge.
Participating healthcare providers can connect with their current and future patients through the system. Other benefits to providers include the ability to utilize the HealthLynked marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancelations using our “real time appointment scheduling” all within our mobile application. Healthcare providers pay a monthly fee to access these HealthLynked services.
For additional information about HealthLynked Corp. visit www.healthlynked.com
Forward Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q and in other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov.
Company Contact:
George O’Leary
Chief Financial Officer
goleary@healthlynked.com
Investor Relations contact:
Jim Hock
Hanover International Inc.
Investor Relations
jh@hanoverintlinc.com
Tremendous one!
So when will they uplist to NASDAQ ? That is the news I would like to see.
Huge volume today lol
HLYK is a great candidate for a buyout. jmo
“Watch” NFusz not uplist by year end
That would be the last nail in the coffin
Soon!
Buyers will be back at .25
Where is sheriff Joe? I was under the impression he would put an end to the manipulation games.
That's quite a guarantee. Is that insider info? Or just a guarantee guess?
that was quick
They appear to be on the right track
I bought at .08 and i now feel i will get more for .05
Not happy with results and the silver tung of the salesman.
Well said
I like Rory and have total respect for the way he conducts himself.
Let this play out and we will all be happy.
HAPPY FATHERS DAY
Great post yerboss
Gotta love fusz
I did not sell any today because I BELIEVE in the company. And Rory seems determined to make this work.
Great job Roach2 wish you the best with your company
Good stuff Thanks
That drop kept feeding off stop losses
This is just a bad week for NEWS, it is a short week before Easter,most company's do not release good news on a short week.But we probably will see the 10K this week.
It is a good time to get it out of the way.
I still expect this to drop all week.Maybe down to 1.40
Keep the faith
Because it will be in a filling. Do not get me wrong I have been here since .o8. I think some will not look at that as favorable.
It will have a psychological impact and it can come at any time. Like tomorrow after the bell.
You may see a dip when they release the 10k
Float is tighter than Dicks hatband
Thanks for all you guys have done